Contact this trialFirst, we need to learn more about you.
QX1206 for Type 2 Diabetes and Fatty Liver Disease
Recruiting1 awardPhase 1
Toronto
This trial is testing a new drug called QX1206 in patients with Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease. They will monitor patients' lab tests and measurements before and during
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service